What does Dr. Daan DETROYER Nefrologie do?

Dr. Daan DETROYER Nefrologie is a specialist medical practice in Zandhoven. Private Limited, started on 1 August 2016, 2 establishments.

What is the address of Dr. Daan DETROYER Nefrologie?

The registered office of Dr. Daan DETROYER Nefrologie is located at Ringlaan 150c, 2240 Zandhoven.

Is Dr. Daan DETROYER Nefrologie still active?

Yes. According to the CBE (16 September 2026) Dr. Daan DETROYER Nefrologie is active, legal situation “Normale toestand”, started on 1 August 2016.

Is Dr. Daan DETROYER Nefrologie registered on Peppol?

Yes, Dr. Daan DETROYER Nefrologie is registered on the Peppol network with ID 0208:0660595140.

What is the enterprise number of Dr. Daan DETROYER Nefrologie?

The enterprise number of Dr. Daan DETROYER Nefrologie is BE0660595140.

When was Dr. Daan DETROYER Nefrologie founded?

Dr. Daan DETROYER Nefrologie was founded on 1 August 2016.

Who are the directors of Dr. Daan DETROYER Nefrologie?

According to the 2025 annual accounts, the directors of Dr. Daan DETROYER Nefrologie are: Daan Detroyer.

Is Dr. Daan DETROYER Nefrologie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 August 2016; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 2 establishments in the CBE.

How much profit did Dr. Daan DETROYER Nefrologie make in 2025?

Dr. Daan DETROYER Nefrologie posted a profit after taxes of € 315,651 in financial year 2025.

What is the revenue of Dr. Daan DETROYER Nefrologie?

As a small company, Dr. Daan DETROYER Nefrologie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 416,633.

Dr. Daan DETROYER Nefrologie (Private Limited)

Dossier Dr. Daan DETROYER Nefrologie, printed on 16 September 2026 from databakkes.be/en/0660595140/dr-daan-detroyer-nefrologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Daan DETROYER Nefrologie from Zandhoven, company number BE0660595140, closed financial year 2025 with a result of € 315,651 after tax. For that financial year Dr. Daan DETROYER Nefrologie recorded a gross margin of € 416,633 and equity of € 34,940. Compared with financial year 2024, the result moved from € 218,331 to € 315,651. Profitable, and profit is growing. The buffer shrank hard: equity is 90 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on March 31, 2026.

What it is worth Shrank hard

€ 34,940

▼ 90% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 315,651

▲ 45% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 251,086

▲ 78% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 645,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 2,957

▲ 43% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 24,538

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 408,640 Gross margin 2022: € 408,640 First fiscal year in the series	€ 286,578 Gross margin 2023: € 286,578 ▼ 30% vs 2022 (€ 408,640) Unfavourable step	€ 293,850 Gross margin 2024: € 293,850 ▲ 3% vs 2023 (€ 286,578) Favourable step	€ 416,633 Gross margin 2025: € 416,633 ▲ 42% vs 2024 (€ 293,850) Favourable step	▲ 42%
Profit after taxes	€ 301,787 Profit after taxes 2022: € 301,787 First fiscal year in the series	€ 208,365 Profit after taxes 2023: € 208,365 ▼ 31% vs 2022 (€ 301,787) Unfavourable step	€ 218,331 Profit after taxes 2024: € 218,331 ▲ 5% vs 2023 (€ 208,365) Favourable step	€ 315,651 Profit after taxes 2025: € 315,651 ▲ 45% vs 2024 (€ 218,331) Favourable step	▲ 45%
Equity	€ 587,593 Equity 2022: € 587,593 First fiscal year in the series	€ 795,958 Equity 2023: € 795,958 ▲ 35% vs 2022 (€ 587,593) Favourable step	€ 364,289 Equity 2024: € 364,289 ▼ 54% vs 2023 (€ 795,958) Unfavourable step	€ 34,940 Equity 2025: € 34,940 ▼ 90% vs 2024 (€ 364,289) Unfavourable step	▼ 90%
Total debts	€ 36,177 Total debts 2022: € 36,177 First fiscal year in the series	€ 25,890 Total debts 2023: € 25,890 ▼ 28% vs 2022 (€ 36,177) Favourable step	€ 2,496 Total debts 2024: € 2,496 ▼ 90% vs 2023 (€ 25,890) Favourable step	€ 328,690 Total debts 2025: € 328,690 ▲ € 326,194 vs 2024 (€ 2,496) Unfavourable step	▲ € 326,194
Cash	€ 486,483 Cash 2022: € 486,483 First fiscal year in the series	€ 671,787 Cash 2023: € 671,787 ▲ 38% vs 2022 (€ 486,483) Favourable step	€ 141,040 Cash 2024: € 141,040 ▼ 79% vs 2023 (€ 671,787) Unfavourable step	€ 251,086 Cash 2025: € 251,086 ▲ 78% vs 2024 (€ 141,040) Favourable step	▲ 78%
Retained profit	€ 568,993 Retained profit 2022: € 568,993 First fiscal year in the series	€ 777,358 Retained profit 2023: € 777,358 ▲ 37% vs 2022 (€ 568,993) Favourable step	€ 345,689 Retained profit 2024: € 345,689 ▼ 56% vs 2023 (€ 777,358) Unfavourable step	€ 16,340 Retained profit 2025: € 16,340 ▼ 95% vs 2024 (€ 345,689) Unfavourable step	▼ 95%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 650,000 Dividend 2024: € 650,000 Unchanged (€ 0) Unchanged	€ 645,000 Dividend 2025: € 645,000 ▼ 1% vs 2024 (€ 650,000) Unchanged	▼ 1%
Balance sheet total	€ 623,770 Balance sheet total 2022: € 623,770 First fiscal year in the series	€ 821,849 Balance sheet total 2023: € 821,849 ▲ 32% vs 2022 (€ 623,770) Unchanged	€ 366,785 Balance sheet total 2024: € 366,785 ▼ 55% vs 2023 (€ 821,849) Unchanged	€ 363,630 Balance sheet total 2025: € 363,630 ▼ 1% vs 2024 (€ 366,785) Unchanged	▼ 1%

Key figures of Dr. Daan DETROYER Nefrologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Daan DETROYER Nefrologie?

What happened at Dr. Daan DETROYER Nefrologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Mar 31, 2026 New annual accounts for financial year 2025: profit of € 315,651 (▲ 45% vs 2024). Source: NBB ↗
Jun 1, 2023 New establishment in Sint-Truiden. KBO
Aug 1, 2016 New establishment in Zandhoven. KBO
2016 Daan Detroyer became a director. NBB
Aug 1, 2016 Start of the company according to the CBE. KBO

In short

From € 301,787 profit in 2022 to € 315,651 profit in 2025.

Paid € 329,719 in corporate taxes since 2022.

Best year ever: 2025, with € 315,651 profit.

Paid out € 1.3 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Daan DETROYER Nefrologie? We notify you, reason included.

Follow Dr. Daan DETROYER Nefrologie

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Daan Detroyer

Dr. Daan DETROYER Nefrologie

Behind Dr. Daan DETROYER Nefrologie is Daan Detroyer.

See the full network in the app

Directors

According to the 2025 annual accounts

Daan Detroyer

Director

since 2016

Establishments

Establishment units

Physical locations of this company

Registered office

Ringlaan 150c

2240 Zandhoven

2.255.147.159

Ringlaan 150 box C

2240 Zandhoven

Active since 1 August 2016

2.347.284.192

Diestersteenweg 100

3800 Sint-Truiden

Active since 1 June 2023

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0660.595.140
VAT number: BE 0660.595.140
Registered office: Ringlaan 150c, 2240 Zandhoven
Names & denominations: Dr. Daan DETROYER Nefrologie
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 1 August 2016
Peppol: Active · Active since 18 Nov 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗